Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c mela...

by Dirk Schadendorf, Ralf Gutzmer, Helen Gogas, Kate Liu, Josep Malvehy, Jean-Jacques Grob, Igor Samoylenko, Joseph J Sacco, Kevin S Gorski, Abraham Anderson, Cheryl A Pickett
Published 2021-03-01

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaResearch in context

by Robert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis, Jonathan S. Zager, John Walker, Jason A. Chesney, Kate Liu, Cheng-Pang Hsu, Cheryl A. Pickett, Janice M. Mehnert
Published 2019-09-01